Increased levels of serum alanine transferase (ALT) and aspartate transferase concentrations which correlates positively with fatty liver and inflammation, decreased in the deh-T3β-treated db/db mice compared to those non-treated db/db mice. The gene discussed is GPT; the disease is fatty liver disease.